64,043 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Purchased by Bryce Point Capital LLC

Bryce Point Capital LLC bought a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the fourth quarter, Holdings Channel.com reports. The fund bought 64,043 shares of the medical instruments supplier’s stock, valued at approximately $1,216,000.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Riverview Trust Co acquired a new stake in DENTSPLY SIRONA during the fourth quarter worth about $26,000. MassMutual Private Wealth & Trust FSB raised its position in DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,232 shares in the last quarter. UMB Bank n.a. lifted its stake in DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 564 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in DENTSPLY SIRONA by 700.0% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock valued at $33,000 after purchasing an additional 1,568 shares in the last quarter. Finally, Quarry LP grew its stake in shares of DENTSPLY SIRONA by 455.0% in the 3rd quarter. Quarry LP now owns 3,036 shares of the medical instruments supplier’s stock valued at $82,000 after purchasing an additional 2,489 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 15,142 shares of the stock in a transaction dated Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the purchase, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. The trade was a 22.66 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. Insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $14.87 on Thursday. The firm has a fifty day moving average of $17.37 and a two-hundred day moving average of $19.93. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock has a market capitalization of $2.96 billion, a price-to-earnings ratio of -7.18, a PEG ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 52 week low of $14.50 and a 52 week high of $33.02.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 4.30%. DENTSPLY SIRONA’s dividend payout ratio is presently -14.07%.

Analysts Set New Price Targets

Several equities analysts recently commented on XRAY shares. Mizuho cut their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday, March 13th. Evercore ISI restated an “in-line” rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating on the stock in a research report on Friday, February 28th. Finally, StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Twelve analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $23.33.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.